Coral Laboratories Share Price | Coral Laboratories Stock Screener
CORALAB
Pharmaceuticals
Share Price BSE
₹469.35
▲
12.60 (2.76%)
As of May 21, 2026, the Coral Laboratories share price (BSE: CORALAB) is ₹469.35, up 2.76% from the previous close, with shares trading between ₹455.20 and ₹490.00, and a 52-week range of ₹362.05–₹777.20.
Check CORALAB price range for the annual price range and momentum.
Use the Coral Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Coral Laboratories Market Cap
₹163.49 Cr.
CORALAB P/E Ratio (TTM)
11.52
Coral Laboratories P/B Ratio
0.76
EPS (TTM)
₹67.61
Dividend Yield
-
Debt to Equity
0.01
CORALAB 52 Week High
₹777.20
Coral Laboratories 52 Week Low
₹362.05
Operating Margin
13.00%
Profit Margin
14.29%
CORALAB Revenue (TTM)
₹98.00
EBITDA
₹21.00
Net Income
₹14.00
Total Assets
₹230.00
Total Equity
₹201.00
Coral Laboratories Share Price Chart
Screen Coral Laboratories share price with an interactive chart. Analyse CORALAB price trends and volatility across different timeframes.
Coral Laboratories Company Profile - Fundamental Screener
Screen Coral Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CORALAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE683E01017
Coral Laboratories Balance Sheet Screener
Screen CORALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 |
| Current Assets | 177 | 154 | 124 | 131 | 129 | 96 | 84 | 72 | 74 | 65 |
| Fixed Assets | 23 | 24 | 25 | 24 | 21 | 23 | 23 | 22 | 18 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 3 | 8 | 8 | 3 | 4 | 4 | 4 | 4 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 201 | 178 | 155 | 156 | 137 | 116 | 114 | 116 | 109 | 70 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 198 | 174 | 151 | 153 | 133 | 112 | 110 | 113 | 106 | 67 |
Coral Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Coral Laboratories income statement and profit fundamentals.
Analyze CORALAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Coral Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 98 | 124 | 90 | 85 | 80 | 100 | 77 | 96 | 97 | 99 | 80 | 62 |
| Expenses | 77 | 89 | 67 | 74 | 67 | 81 | 65 | 79 | 77 | 72 | 61 | 47 |
| EBITDA | 21 | 35 | 23 | 11 | 13 | 20 | 11 | 17 | 20 | 27 | 19 | 15 |
| Operating Profit % | 13.00% | 23.00% | 19.00% | 5.00% | 11.00% | 16.00% | 8.00% | 13.00% | 16.00% | 24.00% | 21.00% | 21.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 19 | 33 | 21 | 8 | 12 | 18 | 9 | 16 | 18 | 25 | 17 | 12 |
| Tax | 5 | 8 | 5 | 2 | 3 | 4 | 2 | 5 | 6 | 8 | 5 | 3 |
| Net Profit | 14 | 24 | 16 | 6 | 9 | 14 | 7 | 10 | 12 | 16 | 12 | 10 |
| EPS | 39.10 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 | 34.84 | 45.61 | 34.70 | 26.79 |
Coral Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen CORALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -6 | 13 | 6 | 1 | -4 | -1 | 14 | 11 | 5 |
| Investing Activities | 0 | 1 | -3 | -6 | 0 | -2 | 3 | -13 | -10 | -3 |
| Financing Activities | 3 | 0 | -6 | 0 | 0 | 4 | -1 | -3 | 1 | 0 |
| Net Cash Flow | 1 | -4 | 4 | 0 | 1 | -2 | 1 | -2 | 2 | 2 |
Coral Laboratories Shareholding Pattern Screener
See Coral Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Coral Laboratories promoter holding and ownership changes for CORALAB on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.14% | 0.23% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.93% | 20.91% | 20.76% | 20.80% | 20.52% | 20.82% | 20.33% | 21.18% |
| Other Holding | 8.56% | 7.58% | 7.72% | 7.69% | 7.97% | 7.52% | 7.93% | 7.31% |
| Shareholder Count | 4,084 | 4,105 | 4,213 | 4,286 | 4,208 | 4,098 | 3,831 | 3,949 |
Coral Laboratories Share Dividend Screener - Share Yield Analysis
Check Coral Laboratories dividend history with payout and yield data.
View Coral Laboratories dividend details including ex-dates and amounts for CORALAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹2.00 | 2.04% |
| 2018-March | ₹2.00 | 0.63% |
| 2017-March | ₹5.00 | 0.84% |
Coral Laboratories Stock Index Membership
See which indices include Coral Laboratories stock.
Check CORALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Coral Laboratories Market Events Screener - Corporate Actions
Get Coral Laboratories corporate actions including splits, bonuses, and buybacks.
Check Coral Laboratories stock events that may affect CORALAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.50 /share | -28.37% | ||
| Annual General Meeting | NA | 21.88% | ||
| Dividend | ₹ 2.00 /share | 23.19% | ||
| Annual General Meeting | NA | -5.28% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 9.27% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.41% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.21% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.18% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -8.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.11% |
Coral Laboratories Competitors Screener - Peer Comparison
Screen CORALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Coral Laboratories Company Announcements - News Screener
Screen CORALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-13 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-05-13 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-27 | Regarding Receipt Of Notice Under Section 18 Of MSMED Act 2006. | - |
| 2026-04-23 | Board Meeting Outcome for Appointment Of Mr. Diwakar Unnikrishna Menon (ACS: 8791) As Company Secretary And Compliance Officer Of The Company | - |
| 2026-04-23 | Appointment Of Mr. Diwakar Unnikrishna Menon (ACS: 8791) As Company Secretary And Compliance Officer Of The Company | - |
| 2026-04-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-06 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-04-02 | Re-Appointment Of Mr. Malay Doshi (DIN: 09186000) As An Independent Director Of The Company | - |
| 2026-04-02 | Board Meeting Outcome for Outcome Of The Board Meeting Held On April 2 2026 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-23 | Completion Of Capacity Expansion At Dehradun Plant | - |
| 2026-02-13 | Financial Result For The Quarter Ended December 31 2026 | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 13 2026 | - |
| 2026-02-05 | Board Meeting Intimation for Intimation Of Board Meeting To Consider Financial Result For The Quarter And Nine Months Ended On December 31 2025 | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-12-23 | Closure of Trading Window | - |
| 2025-11-14 | Results - Financial Results For Quarter And Half Year Ended September 30 2025 | - |